Case Study
Increasing HCP Disease Awareness and Intent-To-Screen by 2X
A biopharma company developing treatment for rare seizure disorders including LGS and TSC sought to increase new adult diagnoses. The challenge: low HCP awareness and difficulty reaching "no-see" providers through conventional outreach. RMN deployed a multi-specialty digital education program targeting neurologists and adult epileptologists.
What’s Inside
- Reaching no-see neurologists through digital content at scale
- Cross-specialty targeting across adult neurology and epileptology
- 2x increase in HCP disease awareness among engaged physicians
- 2x increase in intent-to-screen measured post-engagement
